Literature DB >> 15194502

Ligand stimulation of CD155alpha inhibits cell adhesion and enhances cell migration in fibroblasts.

Toshiyuki Oda1, Seii Ohka, Akio Nomoto.   

Abstract

CD155 (poliovirus receptor) localizes in cell-matrix adhesions and cell-cell junctions, but its role in the regulation of cell adhesion and cell motility has not been investigated. We identified a conserved immunoreceptor tyrosine-based inhibitory motif (ITIM) in the cytoplasmic domain of human CD155alpha. The ITIM was tyrosine-phosphorylated upon binding of anti-CD155 monoclonal antibody D171, poliovirus, and DNAM-1 (CD226) to human CD155alpha, and recruited SH2-domain-containing tyrosine phosphatase-2 (SHP-2). After CD155alpha stimulation with its ligands, cell adhesion was inhibited and cell motility was enhanced, effects that were associated with the phosphorylation of ITIM by Src kinases and accompanied by dephosphorylation of focal adhesion kinase and paxillin. These effects were abolished by introducing a point-mutation in Y398F into the ITIM of CD155alpha and by coexpression of a dominant negative SHP-2 mutant with CD155alpha. These results suggest that CD155alpha plays a role in the regulation of cell adhesion and cell motility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194502     DOI: 10.1016/j.bbrc.2004.05.111

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering.

Authors:  Katharina F Stengel; Kristin Harden-Bowles; Xin Yu; Lionel Rouge; Jianping Yin; Laëtitia Comps-Agrar; Christian Wiesmann; J Fernando Bazan; Dan L Eaton; Jane L Grogan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

2.  TACTILE becomes tangible: CD96 discloses its inhibitory peculiarities.

Authors:  Günter Bernhardt
Journal:  Nat Immunol       Date:  2014-05       Impact factor: 25.606

Review 3.  Neutrophil and monocyte recruitment by PECAM, CD99, and other molecules via the LBRC.

Authors:  David P Sullivan; William A Muller
Journal:  Semin Immunopathol       Date:  2013-12-12       Impact factor: 9.623

Review 4.  Balancing natural killer cell activation through paired receptors.

Authors:  Ludovic Martinet; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

Review 5.  Poliovirus Receptor: More than a simple viral receptor.

Authors:  Jonathan R Bowers; James M Readler; Priyanka Sharma; Katherine J D A Excoffon
Journal:  Virus Res       Date:  2017-09-08       Impact factor: 3.303

6.  Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2.

Authors:  Carolyn B Coyne; Kwang S Kim; Jeffrey M Bergelson
Journal:  EMBO J       Date:  2007-08-23       Impact factor: 11.598

7.  Overexpression of CD155 relates to metastasis and invasion in osteosarcoma.

Authors:  Baobiao Zhuo; Yuan Li; Feng Gu; Zhengwei Li; Qingzeng Sun; Yingchun Shi; Yang Shen; Fengfei Zhang; Rong Wang; Xiaodong Wang
Journal:  Oncol Lett       Date:  2018-03-09       Impact factor: 2.967

Review 8.  Targeting PVR (CD155) and its receptors in anti-tumor therapy.

Authors:  Paola Kučan Brlić; Tihana Lenac Roviš; Guy Cinamon; Pini Tsukerman; Ofer Mandelboim; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

9.  Poliovirus receptor (CD155) regulates a step in transendothelial migration between PECAM and CD99.

Authors:  David P Sullivan; Michael A Seidman; William A Muller
Journal:  Am J Pathol       Date:  2013-01-18       Impact factor: 4.307

10.  Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141.

Authors:  Peter Tomasec; Eddie C Y Wang; Andrew J Davison; Borivoj Vojtesek; Melanie Armstrong; Cora Griffin; Brian P McSharry; Rebecca J Morris; Sian Llewellyn-Lacey; Carole Rickards; Akio Nomoto; Christian Sinzger; Gavin W G Wilkinson
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.